Multidrug resistant tuberculosis (MDR TB) affects half a million people each year. Levofloxacin is advised for preventive treatment based on observational data, however evidence...
Ryoncil has been approved for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), a life-threatening condition that may result from blood stem cell transplantation...
A recent study has estimated disease frequency of herpes simplex virus (HSV) infections and genital ulcer disease (GUD). The estimates suggest that about 846...
On October 22, 2024, a surgical team performed the first fully robotic double lung transplant on a 57-year-old woman with chronic obstructive pulmonary disease...
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...